PubMed CrossRef Klausen MK, Thomsen M, Wortwein G, et al
Some experience injection-site bruising or discomfort
Before confirming a bulk API order, buyers should request and review: Certificate of Analysis (COA) for batch specifications, purity, assay, and test results SDS Safety Data Sheet or MSDS for handling, storage, shipping, and safety information GMP or cGMP supplier details where available USDMF, CEP, EU-GMP certificate, or COS availability where applicable and subject to inquiry Method of analysis or product specification sheet Batch record summary, where supplier permits Export invoice and packing documentation End-Use Declaration EUD support where required Quality, inspection, or supplier qualification records where applicable Pharmint helps buyers structure documentation requests before supplier matching
The dosage is titrated every 4 weeks
Dosing typically begins at a lower dose, suggested initiation of 20 units (0.2 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 14: Inject 20 units (0.2 mL) one time per week Weeks 58: Inject 40 units (0.4 mL) one time per week Weeks 912: Inject 70 units (0.7 mL) one time per week Weeks 1316: Inject 90 units (0.9 mL) one time per week Weeks 1720: Inject 120 units (1.2 mL) one time per week Week 21+: Inject 140 units (1.4 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs
